PURPOSE: We examined whether an increased distance to a urologist is associated with a delayed diagnosis of prostate cancer among black and white patients, as manifested by higher risk disease at diagnosis. MATERIALS AND METHODS: North Carolina Central Cancer Registry data were linked to Medicare claims for patients with incident prostate cancer diagnosed in 2004 to 2005. Straight-line distances were calculated from the patient home to the nearest urologist. Race stratified multivariate ordinal logistic regression was used to examine the association between distance to a urologist and prostate cancer risk group (low, intermediate, high or very high/metastasis) at diagnosis for black and white patients while accounting for age, comorbidity, marital status and diagnosis year. An overall model was then used to examine the distance × race interaction effect. RESULTS: Included in analysis were 1,720 white and 531 black men. In the overall cohort the high risk cancer rate increased monotonically with distance to a urologist, including 40% for 0 to 10, 45% for 11 to 20 and 57% for greater than 20 miles. Correspondingly the low risk cancer rate decreased with longer distance. On race stratified multivariate analysis longer distance was associated with higher risk prostate cancer for white and black patients (p = 0.04 and <0.01, respectively) but the effect was larger in the latter group. The distance × race interaction term was significant in the overall model (p = 0.03). CONCLUSIONS: Longer distance to a urologist may disproportionally impact black patients. Decreasing modifiable barriers to health care access, such as distance to care, may decrease racial disparities in prostate cancer.
PURPOSE: We examined whether an increased distance to a urologist is associated with a delayed diagnosis of prostate cancer among black and whitepatients, as manifested by higher risk disease at diagnosis. MATERIALS AND METHODS:North Carolina Central Cancer Registry data were linked to Medicare claims for patients with incident prostate cancer diagnosed in 2004 to 2005. Straight-line distances were calculated from the patient home to the nearest urologist. Race stratified multivariate ordinal logistic regression was used to examine the association between distance to a urologist and prostate cancer risk group (low, intermediate, high or very high/metastasis) at diagnosis for black and whitepatients while accounting for age, comorbidity, marital status and diagnosis year. An overall model was then used to examine the distance × race interaction effect. RESULTS: Included in analysis were 1,720 white and 531 black men. In the overall cohort the high risk cancer rate increased monotonically with distance to a urologist, including 40% for 0 to 10, 45% for 11 to 20 and 57% for greater than 20 miles. Correspondingly the low risk cancer rate decreased with longer distance. On race stratified multivariate analysis longer distance was associated with higher risk prostate cancer for white and black patients (p = 0.04 and <0.01, respectively) but the effect was larger in the latter group. The distance × race interaction term was significant in the overall model (p = 0.03). CONCLUSIONS: Longer distance to a urologist may disproportionally impact black patients. Decreasing modifiable barriers to health care access, such as distance to care, may decrease racial disparities in prostate cancer.
Authors: J M Vahl; A von Witzleben; C Welke; J Doescher; M N Theodoraki; M Brand; P J Schuler; J Greve; T K Hoffmann; S Laban Journal: Eur Arch Otorhinolaryngol Date: 2021-04-20 Impact factor: 2.503
Authors: Michelle S Wong; David T Grande; Nandita Mitra; Archana Radhakrishnan; Charles C Branas; Katelyn R Ward; Craig E Pollack Journal: Med Care Date: 2017-09 Impact factor: 2.983
Authors: Douglas R Farquhar; Maheer M Masood; Nicholas R Lenze; Philip McDaniel; Angela Mazul; Siddharth Sheth; Adam M Zanation; Trevor G Hackman; Mark Weissler; Jose P Zevallos; Andrew F Olshan Journal: Oral Oncol Date: 2019-01-02 Impact factor: 5.337
Authors: F O'Kelly; A Z Thomas; D Murray; P Lee; R F O'Carroll; P Nicholson; H Forristal; N Swan; D Galvin; D Mulvin; D M Quinlan Journal: Ir J Med Sci Date: 2013-02-17 Impact factor: 1.568
Authors: Anne-Marie Meyer; Andrew F Olshan; Laura Green; Adrian Meyer; Stephanie B Wheeler; Ethan Basch; William R Carpenter Journal: N C Med J Date: 2014 Jul-Aug
Authors: Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster Journal: Cancer Date: 2013-11-20 Impact factor: 6.860
Authors: Kathleen E Sullivan; Jennifer M Puck; Luigi D Notarangelo; Ramsay Fuleihan; Tara Caulder; Connie Wang; Marcia Boyle; Charlotte Cunningham-Rundles Journal: J Clin Immunol Date: 2014-04-08 Impact factor: 8.317
Authors: Michael A Poch; Diana Mehedint; Dawn J Green; Rochelle Payne-Ondracek; Elizabeth T H Fontham; Jeannette T Bensen; Kristopher Attwood; Gregory E Wilding; Khurshid A Guru; Willie Underwood; James L Mohler; Hannelore V Heemers Journal: Prostate Date: 2012-12-31 Impact factor: 4.104
Authors: Daniel H Kwon; Diana M Tisnado; Nancy L Keating; Carrie N Klabunde; John L Adams; Afshin Rastegar; Mark C Hornbrook; Katherine L Kahn Journal: Cancer Date: 2014-09-05 Impact factor: 6.860